Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Internal Medicine V
Agnieszka Martowicz has not added Biography.
If you are Agnieszka Martowicz and would like to personalize this page please email our Author Liaison for assistance.
Effects of EpCAM overexpression on human breast cancer cell lines.
BMC cancer , 2011 | Pubmed ID: 21281469
Distinct expression patterns of dickkopf genes during late embryonic development of Danio rerio.
Gene expression patterns : GEP Dec, 2011 | Pubmed ID: 21889616
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
BMC cancer , 2012 | Pubmed ID: 23110550
EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.
Molecular cancer , 2013 | Pubmed ID: 23758908
Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.
Histopathology Apr, 2014 | Pubmed ID: 24117877
Synthesis and Biological Activity of Diastereomeric and Geometric Analogs of Calcipotriol, PRI-2202 and PRI-2205, Against Human HL-60 Leukemia and MCF-7 Breast Cancer Cells.
Cancers , 2013 | Pubmed ID: 24202449
Innsbruck Medical University
Karolinska Institute
Agnieszka Martowicz*,1,4,
Johann Kern*,1,2,
Eberhard Gunsilius1,
Gerold Untergasser1,3
1Department of Internal Medicine V, Innsbruck Medical University,
2, Oncotyrol GmbH,
3, Tyrolean Cancer Research Institute,
4Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.